Document Type : Original Research Article
Authors
- Jorge Cea García 1
- Francisco Márquez Maraver 1
- Inmaculada Rodríguez Jiménez 1
- Laura Ríos-Pena 2
- M. Carmen Rubio Rodríguez 3
1 Clinical Management Unit for Obstetrics and Gynecology, University Hospital Virgen Macarena, Seville, Spain
2 Institute of Science and Technology, Loyola University, Dos Hermanas, Seville, Spain
3 Department of Radiation Oncology, HM Hospitals, University Hospital Sanchinarro, Madrid, Spain
Abstract
Background & Objective: We aimed to compare sexual function and body image among cervical cancer survivors.
Materials & Methods: Between August 1, 2016 and January 31, 2019, we conducted a prospective study with 104 participants. The FSFI and the FACT-Cx v.4.0 (B4 and C7) were the measurement tools.
Results: Forty–seven and twelve hundredths percent reported sexual activity, with the surgical group considerably less sexually active than the non-surgical group (63% vs. 100%, P=0.0003). Throughout the follow-up, we found no significant changes in sexual function (P>0.05). A diagnosis of sexual dysfunction was made in 60.58% of cervical cancer survivors, 80.65% following surgery alone, and in 100% after radiotherapy and chemotherapy. In comparison with survivors who did not receive radiotherapy, irradiated survivors had lower FSFI total scores (1.2 vs. 21.4, P T1=0.0001; 2.1 vs. 21.75, P T2=0.0002). In comparison with the non–chemotherapy group, the chemotherapy group's scores were considerably lower (1.2 vs. 21.15, P T1 <0.0001; 2.4 vs. 18.95, P T2=0.004). We detected no significant changes in body image scores (P=0.184). Except for T1 time assessment (2 vs. 3, P T1=0.016), no differences in body image between the surgical and non-surgical groups were found throughout the follow-up (P T2=0.992; P T3=0.207; P T4=0.139).
Conclusion: The rate of female sexual dysfunction was 60.58%, prevailing after therapeutic multimodality, radiotherapy, and chemotherapy. Throughout the follow–up, we discovered no significant changes in sexual activity and function, or in body image. In terms of body image, there were no significant differences between the surgical and non–surgical groups.
Keywords
Main Subjects
1. Hayes R, Dennerstein L. The Impact of Aging on Sexual Function and Sexual Dysfunction in Women: A Review of Population‐Based Studies. Sex Med. 2005;2(3):317-30. [DOI:10.1111/j.1743-6109.2005.20356.x] [PMID]
2. Zhou W, Yang X, Dai Y, Wu Q, He G, Yin G. Survey of cervical cancer survivors regarding quality of life and sexual function. J Cancer Res Ther. 2016;12(2):938-44. [DOI:10.4103/0973-1482.175427] [PMID]
3. Cianci S, Tarascio M, Arcieri M, La Verde M, Martinelli C, Capozzi VA, et al. Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review. Medicina. 2023;59(4):704. [DOI:10.3390/medicina59040704] [PMID] [PMCID]
4. Wenzel L, DeAlba I, Habbal R, Kluhsman BC, Fairclough D, Krebs LU, et al. Quality of life in long-term cervical cancer survivors. Gynecol Oncol. 2005;97(2):310-7. [DOI:10.1016/j.ygyno.2005.01.010] [PMID]
5. Bjelic-Radisic V, Jensen PT, Vlasic KK, Waldenstrom A-C, Singer S, Chie W, et al. Quality of life characteristics inpatients with cervical cancer. Eur J Cancer. 2012;48(16):3009-18. [DOI:10.1016/j.ejca.2012.05.011] [PMID]
6. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, et al. Changes in the Demographics and Perioperative Care of Stage IA2/IB1 Cervical Cancer over the Past 16 Years. Gynecol Oncol. 2001;81(2):133-7. [DOI:10.1006/gyno.2001.6158] [PMID]
7. Fadhilla HN, Mudigdo A, Rahardjo SS. Effect of age and socio economic status on the quality of life of patients with cervical cancer undertaking chemotherapy at Dr. Moewardi Hospital Surakarta. J Epidemiol Public Health. 2017;2(1):11-9. [DOI:10.26911/jepublichealth.2017.02.01.02]
8. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. Cancer. 2004;100(1):97-106. [DOI:10.1002/cncr.11877] [PMID]
9. Greimel ER, Winter R, Kapp KS, Haas J. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology. 2009;18(5):476-82. [DOI:10.1002/pon.1426] [PMID]
10. Chang C-P, Wilson CM, Rowe K, Snyder J, Dodson M, Deshmukh V, et al. Sexual dysfunction among gynecologic cancer survivors in a population-based cohort study. Support Care Cancer. 2022;31(1):51. [DOI:10.1007/s00520-022-07469-6] [PMID] [PMCID]
11. Afiyanti Y, Milanti A. Physical sexual and intimate relationship concerns among Indonesian cervical cancer survivors: A phenomenological study. Nurs Health Sci. 2013;15(2):151-6. [DOI:10.1111/nhs.12006] [PMID]
12. Briedite I, Ancane G, Ancans A, Erts R. Insufficient Assessment of Sexual Dysfunction: A Problem in Gynecological Practice. Medicina. 2013;49(7):315-20. [DOI:10.3390/medicina49070049]
13. Ceccaroni M, Roviglione G, Spagnolo E, Casadio P, Clarizia R, Peiretti M, et al. Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy: a multicenter comparative study. Anti Res. 2012;32(2):581-8.
14. Laumann EO, Glasser DB, Neves RCS, Moreira ED. A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. 2009;21(3):171-8. [DOI:10.1038/ijir.2009.7] [PMID]
15. Pauls RN, Kleeman SD, Segal JL, Silva WA, Goldenhar LM, Karram MM. Practice patterns of physician members of the American Urogynecologic Society regarding female sexual dysfunction: results of a national survey. Intl Urog J. 2005;16(6):460-7. [DOI:10.1007/s00192-005-1286-5] [PMID]
16. Ratner ES, Foran KA, Schwartz PE, Minkin MJ. Sexuality and intimacy after gynecological cancer. Maturitas. 2010;66(1):23-6. [DOI:10.1016/j.maturitas.2010.01.015] [PMID]
17. Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18(4):382-95. [DOI:10.1038/sj.ijir.3901440] [PMID]
18. Song T, Choi CH, Lee Y-Y, Kim T-J, Lee J-W, Kim B-G, Bae D-S. Sexual Function After Surgery for Early-Stage Cervical Cancer: Is There a Difference in it According to the Extent of Surgical Radicality? J Sexl Med. 2012;9(6):1697-704. [DOI:10.1111/j.1743-6109.2012.02723.x] [PMID]
19. Thiel RdRC, Dambros M, Palma PCR, Thiel M, Riccetto CLZ, Ramos MdF. Tradução para português, adaptação cultural e validação do Female Sexual Function Index. Revista Brasileira de Ginecologia e Obstetrícia. 2008;30. [DOI:10.1590/S0100-72032008001000005] [PMID]
20. Anastasiadis AG, Davis AR, Ghafar MA, Burchardt M, Shabsigh R. The epidemiology and definition of female sexual disorders. World J Urol. 2002;20(2):74-8. [DOI:10.1007/s00345-002-0272-5] [PMID]
21. Castelo-Branco C, Blumel JE, Araya H, Riquelme R, Castro G, Haya J, Gramegna G. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. Obstet Gynecol. 2003;23(4):426-30. [DOI:10.1080/0144361031000120978] [PMID]
22. Dunn KM, Jordan K, Croft PR, Assendelft WJJ. Systematic Review of Sexual Problems: Epidemiology and Methodology. J Sex Marital Ther. 2002;28(5):399-422. [DOI:10.1080/00926230290001529] [PMID]
23. Kadri N, McHichi Alami KH, McHakra Tahiri S. Sexual dysfunction in women: population based epidemiological study. Arch Womens Ment Health. 2002;5(2):59-63. [DOI:10.1007/s00737-002-0141-7] [PMID]
24. West SL, Vinikoor LC, Zolnoun D. A Systematic Review of the Literature on Female Sexual Dysfunction Prevalence and Predictors. Annu Rev Sex Res. 2004;15(1):40-172.
25. Cohen PG. Sexual dysfunction in the United States. JAMA. 1999;282(13):1229. [DOI:10.1001/jama.282.13.1229] [PMID]
26. Kumar S, Rana ML, Verma K, Singh N, Sharma AK, Maria AK, et al. PrediQt-Cx: post treatment health related quality of life prediction model for cervical cancer patients. PloS one. 2014;9(2):e89851. [DOI:10.1371/journal.pone.0089851] [PMID] [PMCID]
27. Derks M, Lonkhuijzen LRCWv, Bakker RM, Stiggelbout AM, Kroon CDd, Westerveld H, et al. Long-Term Morbidity and Quality of Life in Cervical Cancer Survivors: A Multicenter Comparison Between Surgery and Radiotherapy as Primary Treatment. Int J Gynecol Cancer. 2017;27(2):350-6. [DOI:10.1097/IGC.0000000000000880] [PMID]
28. Tramacere F, Lancellotta V, Casà C, Fionda B, Cornacchione P, Mazzarella C, et al. Assessment of Sexual Dysfunction in Cervical Cancer Patients after Different Treatment Modality: A Systematic Review. Medicina. 2022;58(9):1223. [DOI:10.3390/medicina58091223] [PMID] [PMCID]
29. Wang X, Chen C, Liu P, Li W, Wang L, Liu Y. The morbidity of sexual dysfunction of 125 Chinese women following different types of radical hysterectomy for gynaecological malignancies. Arch Gynecol Obstet. 2018;297(2):459-66. [DOI:10.1007/s00404-017-4625-0] [PMID]
30. Wang H-Z, He R-J, Zhuang X-R, Xue Y-W, Lu Y. Assessment of long-term sexual function of cervical cancer survivors after treatment: A cross-sectional study. J Obstet Gynaecol Res. 2022;48(11):2888-95. [DOI:10.1111/jog.15406] [PMID] [PMCID]
31. Carter J, Sonoda Y, Baser RE, Raviv L, Chi DS, Barakat RR, et al. A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecol Oncol. 2010;119(2):358-65. [DOI:10.1016/j.ygyno.2010.07.016] [PMID] [PMCID]
32. Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, et al. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study. Gynecol Oncol. 2012;124(3):389-94. [DOI:10.1016/j.ygyno.2011.09.041] [PMID]
33. Ditto A, Bogani G, Leone Roberti Maggiore U, Martinelli F, Chiappa V, Lopez C, et al. Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer. J Gynecol Oncol. 2018;29(3):e41. [DOI:10.3802/jgo.2018.29.e41] [PMID] [PMCID]
34. Kim HS, Kim K, Ryoo SB, Seo JH, Kim SY, Park JW, et al. Conventional versus nerve-sparing radical surgery for cervical cancer: a meta-analysis. J Gynecol Oncol. 2015;26(2):100-10. [DOI:10.3802/jgo.2015.26.2.100] [PMID] [PMCID]
35. Loizzi V, Cormio G, Lobascio PL, Marino F, De Fazio M, Falagario M, et al. Bowel Dysfunction following Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Prospective Study. Oncology. 2014;86(4):239-43. [DOI:10.1159/000362213] [PMID]
36. Sun H, Cao D, Shen K, Yang J, Xiang Y, Feng F, et al. Piver Type II vs. Type III hysterectomy in the treatment of early-stage cervical cancer: midterm follow-up results of a randomized controlled trial. Front Oncol. 2018;8:568. [DOI:10.3389/fonc.2018.00568] [PMID] [PMCID]
37. Wu J, Ye T, Lv J, He Z, Zhu J. Laparoscopic Nerve-Sparing Radical Hysterectomy vs Laparoscopic Radical Hysterectomy in Cervical Cancer: A Systematic Review and Meta-Analysis of Clinical Efficacy and Bladder Dysfunction. J Minim Invasive Gynecol. 2019;26(3):417-26.e6. [DOI:10.1016/j.jmig.2018.10.012] [PMID]
38. Plotti F, Nelaj E, Sansone M, Antonelli E, Altavilla T, Angioli R, et al. Sexual Function After Modified Radical Hysterectomy (Piver II/Type B) vs. Classic Radical Hysterectomy (Piver III/Type C2) for Early Stage Cervical Cancer. A Prospective Study. J Sex Med. 2012;9(3):909-17. [DOI:10.1111/j.1743-6109.2011.02581.x] [PMID]
39. Xiao M, Gao H, Bai H, Zhang Z. Quality of life and sexuality in disease-free survivors of cervical cancer after radical hysterectomy alone: a comparison between total laparoscopy and laparotomy. Medicine. 2016;95(36):e4787. [DOI:10.1097/MD.0000000000004787] [PMID] [PMCID]
40. Cibula D, Velechovska P, Sláma J, Fischerova D, Pinkavova I, Pavlista D, et al. Late morbidity following nerve-sparing radical hysterectomy. Gynecol Oncol. 2010;116(3):506-11. [DOI:10.1016/j.ygyno.2009.10.061] [PMID]
41. Bogani G, Serati M, Nappi R, Cromi A, di Naro E, Ghezzi F. Nerve‐Sparing Approach Reduces Sexual Dysfunction in Patients Undergoing Laparoscopic Radical Hysterectomy. Sex Med. 2014;11(12):3012-20. [DOI:10.1111/jsm.12702] [PMID]
42. Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker N. Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psychooncology. 2003;12(3):267-79. [DOI:10.1002/pon.639] [PMID]
43. Chan JL, Letourneau J, Salem W, Cil AP, Chan S-W, Chen L-m, et al. Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery. Gynecol Oncol. 2015;139(1):141-7. [DOI:10.1016/j.ygyno.2015.07.105] [PMID]
44. Xu LI, Sun F-Q, Wang Z-H. Radical trachelectomy versus radical hysterectomy for the treatment of early cervical cancer: a systematic review. Acta Obstetricia et Gynecologica Scandinavica. 2011;90(11):1200-9. [DOI:10.1111/j.1600-0412.2011.01231.x] [PMID]
45. Baessler K, Windemut S, Chiantera V, Köhler C, Sehouli J. Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical cancer. Clin Transl Oncol. 2021;23(11):2335-43. [DOI:10.1007/s12094-021-02632-7] [PMID] [PMCID]
46. Barnaś E, Skręt-Magierło J, Skręt A, Bidziński M. The quality of life of women treated for cervical cancer. Eur J Oncol Nurs. 2012;16(1):59-63. [DOI:10.1016/j.ejon.2011.03.001] [PMID]
47. Yang L, Yuan J, Zeng X, Xi M, Wang H. The outcomes and quality of life of young patients undergoing adjuvant radiotherapy versus non-radiotherapy following surgery treating early FIGO stage cervical squamous cell cancer in southwestern China. Sci Rep. 2020;10(1):9583. [DOI:10.1038/s41598-020-66661-y] [PMID] [PMCID]
48. Pasek M, Urbański K, Suchocka L. Quality of life in advanced cervical cancer patients subjected to radiotherapy-a WHOQOL BREF questionnaire study. Psychooncologie. 2013;7(2):107-12. [DOI:10.1007/s11839-013-0413-7]
49. Yavas G, Yavas C, Dogan NU, Ilhan TT, Dogan S, Karabagli P, et al. Pelvic radiotherapy does not deteriorate the quality of life of women with gynecologic cancers in long-term follow-up: A 2 years prospective single-center study. J Cancer Research Ther. 2017;13(3):524-32. [DOI:10.4103/0973-1482.187243]
50. De Rosa N, Lavitola G, Giampaolino P, Morra I, Nappi C, Bifulco G. Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study. Biomed Res Int. 2017;2017:7513610. [DOI:10.1155/2017/7513610] [PMID] [PMCID]
51. Pieterse QD, Kenter GG, Maas CP, Kroon CDd, Creutzberg CL, Trimbos JBMZ, Kuile MMT. Self-Reported Sexual, Bowel and Bladder Function in Cervical Cancer Patients Following Different Treatment Modalities: Longitudinal Prospective Cohort Study. Int J Gynecol Cancer. 2013;23(9):1717-25. [DOI:10.1097/IGC.0b013e3182a80a65] [PMID]
52. Undurraga M, Loubeyre P, Dubuisson J-B, Schneider D, Petignat P. Early-stage cervical cancer: is surgery better than radiotherapy? Expert Rev Anticancer Ther. 2010;10(3):451-60. [DOI:10.1586/era.09.192] [PMID]
53. Hofsjö A, Bergmark K, Blomgren B, Jahren H, Bohm-Starke N. Radiotherapy for cervical cancer - impact on the vaginal epithelium and sexual function. Acta Oncol. 2018;57(3):338-45. [DOI:10.1080/0284186X.2017.1400684] [PMID]
54. Lammerink EAG, de Bock GH, Pras E, Reyners AKL, Mourits MJE. Sexual functioning of cervical cancer survivors: a review with a female perspective. Maturitas. 2012;72(4):296-304. [DOI:10.1016/j.maturitas.2012.05.006] [PMID]
55. Gondi V, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, et al. Severe Late Toxicities Following Concomitant Chemoradiotherapy Compared to Radiotherapy Alone in Cervical Cancer: An Inter-era Analysis. Int J Radiat Oncol Biol Phys. 2012;84(4):973-82. [DOI:10.1016/j.ijrobp.2012.01.064] [PMID] [PMCID]
56. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, et al. Quality of Life and Sexual Functioning in Cervical Cancer Survivors. Clin Oncol. 2005;23(30):7428-36. [DOI:10.1200/JCO.2004.00.3996] [PMID]
57. Li C-C, Chang T-C, Tsai Y-F, Chen L. Quality of life among survivors of early-stage cervical cancer in Taiwan: an exploration of treatment modality differences. Qual Life Res. 2017;26:2773-82. [DOI:10.1007/s11136-017-1619-0] [PMID]
58. Schultz WW, Van de Wiel HB, Hahn DE, Bouma J. Psychosexual functioning after treatment for gynecological cancer: an integrative model, review of determinant factors and clinical guidelines. Int J Gynecologic Cancer. 1992;2(6):281-90. [DOI:10.1046/j.1525-1438.1992.02060281.x] [PMID]
59. Kaneyasu Y, Fujiwara H, Nishimura T, Sakurai H, Kazumoto T, Ikushima H, et al. A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan. J Radiat Res. 2021;62(2):269-84. [DOI:10.1093/jrr/rraa107] [PMID] [PMCID]
60. Virtanen H, MÄKinen J, Tenho T, Kiilholma P, PitkÄNen Y, Hirvonen T. Effects of Abdominal Hysterectomy on Urinary and Sexual Symptoms. Br J Urol. 1993;72(6):868-72. [DOI:10.1111/j.1464-410X.1993.tb16288.x] [PMID]
61. Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, Schmidt M, Pilch H, et al. The impact of treatment for genital cancer on quality of life and body image-results of a prospective longitudinal 10-year study. Gynecol Oncol. 2004;94(2):398-403. [DOI:10.1016/j.ygyno.2004.04.025] [PMID]
62. Baser RE, Li Y, Carter J. Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer. 2012;118(18):4606-18. [DOI:10.1002/cncr.26739] [PMID]
63. Stephenson KR, Toorabally N, Lyons L, M. Meston C. Further Validation of the Female Sexual Function Index: Specificity and Associations With Clinical Interview Data. J Sex Ma Ther. 2016;42(5):448-61. [DOI:10.1080/0092623X.2015.1061078] [PMID]
64. Castillo-Ávila IY, Canencia-Padilla J, Zurbarán-Lamadrid M, Pertuz-Cantillo D, Montes-Padilla M, Jiménez-Chacón E. Quality of life in women with cervical cancer, Cartagena (Colombia), 2012. Revista Colom de Obstet Ginecol. 2015;66(1):22-31. [DOI:10.18597/rcog.4]
65. Cella D, Hernandez L, Bonomi AE, Corona M, Vaquero M, Shiomoto G, Baez L. Spanish Language Translation and Initial Validation of the Functional Assessment of Cancer Therapy Quality-of-Life Instrument. Med Care. 1998;36(9):1407-8. [DOI:10.1097/00005650-199809000-00012] [PMID]
66. Rosen C, Brown J, Heiman S, Leiblum C, Meston R, Shabsigh D, et al. The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function. J Sex Marital Ther. 2000;26(2):191-208. [DOI:10.1080/009262300278597] [PMID]
67. Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): Cross-Validation and Development of Clinical Cutoff Scores. J Sex Marital Ther. 2005;31(1):1-20. [DOI:10.1080/00926230590475206] [PMID]
68. Liu H, Yu J, Chen Y, He P, Zhou L, Tang X, et al. Sexual function in cervical cancer patients: Psychometric properties and performance of a Chinese version of the Female Sexual Function Index. Eur J Oncol Nurs. 2016;20:24-30. [DOI:10.1016/j.ejon.2015.06.007] [PMID]
69. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed: Erlbaum Associates; 1988.
70. Machin D, Campbell MJ, Tan SB, Tan SH. Sample size tables for clinical studies: John Wiley & Sons; 2011.
71. Pauler DK, McCoy S, Moinpour C. Pattern mixture models for longitudinal quality of life studies in advanced stage disease. Stat Med. 2003;22(5):795-809. [DOI:10.1002/sim.1397] [PMID]
72. EPIDAT Consellería de Sanidade. Servizo Galego de Saúde. 2023. Available from: [https://www.sergas.es/Saude-publica/EPIDAT]
73. Hellsten C, Lindqvist PG, Sjöström K. A longitudinal study of sexual functioning in women referred for colposcopy: a 2-year follow up. BJOG: Int J Obstet Gynaecol. 2008;115(2):205-11. [DOI:10.1111/j.1471-0528.2007.01503.x] [DOI:10.1111/j.1471-0528.2007.01609.x] [PMID]
74. Ye S, Yang J, Cao D, Lang J, Shen K. A Systematic Review of Quality of Life and Sexual Function of Patients With Cervical Cancer After Treatment. Gynecologic Cancer. 2014;24(7):1146-57. [DOI:10.1097/IGC.0000000000000207] [PMID]
75. Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M. Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys. 2009;73(5):1501-9. [DOI:10.1016/j.ijrobp.2008.06.1905] [PMID]
)
